Primary Pulmonary
 Hypertension (PPH)
 Causes of PAH/PPH
 PAH/PPH Symptoms
 & Diagnosis
 Pictures of PAH/PPH
 PAH/PPH Treatment Options
  • Drugs & Transplantation
  • PAH/PPH Doctors
  • PAH/PPH Clinics
  • Questions For the Doctor
  • Coping With PAH/PPH
 Financial Aid For Patients
 PAH/PPH News
 Site Map
                                          
 Search for information:
 
     Match:
any search words
all search words

Click Here for a Free
Information Packet

FOR MORE INFORMATION
Please call
1-800-923-6376

We will gladly answer your questions and send a free packet with additional
information on:

  • New treatment options
  • New clinical trials
  • Doctors
  • Hazardous jobs and products
  • Financial Assistance

 

 



 
Primary Arterial Hypertension

(Primary Pulmonary Hypertension)

 

Primary Arterial Hypertension News - Menu

Judge rescinds $1.4 million fen-phen verdict

NEW YORK (Reuters) - May 12, 2005 - Wyeth on Thursday said a Philadelphia judge rescinded a verdict against the drugmaker, in which the company had been ordered to pay three Utah women a total of almost $1.4 million for alleged harm from one of the company's recalled "fen-phen" diet drugs.

The Madison, New Jersey-based company said Judge Mark Bernstein of the Philadelphia Court of Common Pleas ruled that the sole expert witness for the women had systematically provided questionable or "illogical" scientific testimony.

Wyeth said Bernstein ordered a new trial in the cases of Lucy Hansen, Joyce Jensen and Mildred Hill, who won their favorable verdict last November.

The company said the judge on Feb. 23 overturned the favorable verdict of a fourth female Utah plaintiff in the same trial -- Geri McMurdie -- who had been awarded $780,000 in compensatory damages.

All four plaintiffs alleged they suffered heart valve damage as a result of taking Pondimin, one of the drugs commonly used in the fen-phen slimming cocktail.

Pondimin and another Wyeth appetite suppressant, Redux, were recalled in 1997 after being linked to heart valve problems and a highly fatal lung condition called primary pulmonary hypertension.

Wyeth has taken charges of over $21 billion since the recall to satisfy claims from former users of the medicines, but still faces about 60,000 lawsuits in the United States. An estimated 6 million Americans took Wyeth's two drugs before they were recalled.


Study links acetaminophen with lung disease

Users of the pain reliever are more likely to have chronic obstructive pulmonary disease or asthma

June 02, 2005 - People with respiratory disease should be cautious in their use of acetaminophen, according to British researchers who found users of the pain reliever were more likely to have asthma and other lung conditions.

Dr. Tricia McKeever of the University of Nottingham and her colleagues say people with lung disease should consult with their doctor over whether to take acetaminophen, and carefully consider the risks and benefits.

The researchers studied nearly 13,500 people, finding that those who reported daily use of acetaminophen were nearly twice as likely as non-users to have asthma or chronic obstructive pulmonary disease (a group of lung conditions including emphysema and chronic bronchitis).

Aspirin and ibuprofen were not associated with lung disease.

Tests indicated that daily acetaminophen users had poorer lung function than non-users, but ibuprofen users actually had improved lung function, as long as they didn't take the medication every day.


FELA suits can offer better relief than worker's comp benefits

By Steve Gonzalez - Edwardsville Bureau
June 30, 2005 - The widow of a Belleville man who worked for Illinois Central Railroad (ICR) filed a Federal Employers’ Liability Act (FELA) lawsuit in Madison County Circuit Court June 27 seeking damages in excess of $50,000 alleging the railroad failed to provide her husband with a reasonably safe place to work.

Passed by the U.S. Congress in 1908, FELA was designed to protect and compensate railroaders who sustained injuries while working. Unlike state worker's compensation law, FELA requires the injured worker to prove that the railroad was "legally negligent," at least in part, in causing an injury.

Mildred Bagwill claims that while working for ICR, her husband Robert was exposed to and inhaled asbestos fibers, free silica, diesel fumes, solvent fumes, gasoline fumes, and other carcinogenic materials that were harmful to his respiratory system which led to his death on Oct. 10, 2002.

According to the complaint, Robert Bagwill suffered from asbestosis, chronic obstructive pulmonary disease, occupational asthma and bronchitis and lung cancer which were diagnosed in July 2002.

Bagwill claims that ICR was negligent by failing to take any effective action to reduce the respiratory irritants her husband was exposed to, failing to test Robert to determine if he suffered from occupational diseases, and failing to instruct Robert of proper methods of use and care of the respiratory irritants.

Under FELA, injured workers can seek compensation for wage losses past and future, medical expenses and treatments, pain and suffering, and for partial or permanent disability. If an employee dies, survivors are entitled to recover damages which they have suffered because of the death.

After proving negligence, the injured worker is entitled to full compensation, which is usually many times greater than that provided by state worker's compensation benefits for non-railroaders which provide benefits on a no-fault basis

Bagwill also claims ICR failed to tell Robert that wearing protective gear could help prevent exposure, failed to take reasonable care to publish, adopt and enforce a safety plan for working with harmful irritants, failed to provide adequate ventilation, and failed to use a degree of care and caution under the circumstances.

According to Bagwill, prior to her husband’s death he suffered great physical pain and suffering, nervous and emotional tension and anxiety, including the fear of imminent death, suffered financial losses, medical expenses, and lost the ability to enjoy life’s pleasures.

“Robert’s surviving family is entitled to be compensated for the present value of financial contribution which he would reasonably be expected to have given to his family, the pecuniary value of services which his spouse might reasonably have expected to receive from him in the future and the loss to his children and all other reasonable damages,” the complaint states.

Bagwill is represented by Daniel Francis of St. Louis. The case has been assigned to Circuit Judge George Moran, Jr.

FELA allows a claim to be brought in federal or state court, whichever better suits the employee’s convenience or purpose. The case may be filed in any city into which a railroad passes, or even where the railroad has no tracks but has a business office.

According to a published report by the Transportation Research Board (TRB), railroad management has argued that the FELA process imposes higher costs on the rail industry than those imposed by the workers’ compensation system on its competitors-primarily the trucking industry. That places railroads at a competitive disadvantage, the rail industry argues.

Rail union leaders contend that FELA is a necessary system to provide fair compensation and to offer incentives to industry to offer a safe working environment.

At the request of Congress, a TRB committee that produced the report compared FELA with other workers’ compensation systems. The committee concluded that while FELA provides higher benefits it can result in delays in payments, involve higher transaction costs, and result in greater costs to railroads.

The committee recommended that industry and labor make constructive changes in the FELA process that could help reduce costs. One means of doing so would be to rely on alternative dispute-resolution mechanisms to reduce the extent of litigation.

Due to the high degree of unionization in the railroad industry, any reductions in injury compensation benefits are likely to be resisted strongly by labor, the TRB concluded.

05 L 592

-------------------
Steve Gonzalez


 


 

FREE
PAH/PPH Patient
Info Packet
PPH Patient Handouts
Click here today,
and get this free patient information packet sent to you quickly.



 Popular Searches  
fen phen
pah symptoms
heart attack
hypertension

 


To Obtain the Best Treatment Info & Financial Assistance contact us for a free PAH/PPH information packet which includes:

Hospital Locations
Clinical Trials
Hazardous Jobs/ Products
New Treatment Options
Doctors
Financial Assistance

Fill out the form below or call 1-800-923-6376.

First Name
Last Name
Address
City
State
Zip

Phone

Email
   
Have you or a loved one been diagnosed or have:
   
Pulmonary Hypertension?

  Yes   No
Primary Pulmonary Hypertension
(PPH)?
  Yes   No
Pulmonary Arterial Hypertension
(PAH)?
  Yes   No

Persistent Pulmonary Hypertension Newborn?

  Yes   No
Have you had a Valve Replacement?

  Yes   No
Are you on a treatment such as Flolan, Tracleer, Remodulin, Rivatio (Viagra), Ventavis, or other?

  Yes   No
Did you or your loved one take Fen Phen or other Diet Drugs?

  Yes   No
Did Mom take any antidepressant while pregnant resulting in a child with a diagnosis of Persistent Pulmonary Hypertension Newborn?
  Yes   No
   

Comment /
Info Request

 

 

 

 

 

 

PAH/PPH Home | PAH/PPH Causes | PAH/PPH Symptoms | PAH/PPH Pictures | Treatment Options | Medications | PAH/PPH Doctor Locator | PAH/PPH Clinic Locator | PAH/PPH Questions | PAH/PPH Support | Patient Handouts | Financial Aid | PAH/PPH News | Site Map